Kristeller 2017.
| Methods |
Study design: RCT Duration: 26 weeks Location: hospital, USA |
| Participants |
Population: 69 people with COPD or heart failure Baseline characteristics: mean age: treatment group 64 years; control group 69 years; male %: treatment group 46%; control group 44%; education level (graduated from high school): treatment group 74%; control group 79%; hospitalisation in the last year %: treatment group 54%; control group 62% Inclusion criteria: aged ≥ 18 years, hospital admission with primary or secondary diagnosis of COPD or heart failure, agreed to take part in monthly counselling sessions (treatment group only) Exclusion criteria: cognitive impairment, dementia, non‐English, discharge to long‐term care or permanent skilled nursing facility, surgery, hospice, at end of life |
| Interventions |
Treatment arms
|
| Outcomes |
Primary outcome: medication adherence Secondary outcomes: medication‐related issues, patient satisfaction, hospital readmissions or ED visits |
| Notes |
Funding: Community Pharmacy Foundation Identifier: NCT02047448 |